Correlation Between Keros Therapeutics and IGM Biosciences
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and IGM Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and IGM Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and IGM Biosciences, you can compare the effects of market volatilities on Keros Therapeutics and IGM Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of IGM Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and IGM Biosciences.
Diversification Opportunities for Keros Therapeutics and IGM Biosciences
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Keros and IGM is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and IGM Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IGM Biosciences and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with IGM Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IGM Biosciences has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and IGM Biosciences go up and down completely randomly.
Pair Corralation between Keros Therapeutics and IGM Biosciences
Given the investment horizon of 90 days Keros Therapeutics is expected to generate 0.5 times more return on investment than IGM Biosciences. However, Keros Therapeutics is 2.01 times less risky than IGM Biosciences. It trades about 0.0 of its potential returns per unit of risk. IGM Biosciences is currently generating about -0.03 per unit of risk. If you would invest 1,113 in Keros Therapeutics on December 4, 2024 and sell it today you would lose (3.00) from holding Keros Therapeutics or give up 0.27% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Keros Therapeutics vs. IGM Biosciences
Performance |
Timeline |
Keros Therapeutics |
IGM Biosciences |
Keros Therapeutics and IGM Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Keros Therapeutics and IGM Biosciences
The main advantage of trading using opposite Keros Therapeutics and IGM Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, IGM Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IGM Biosciences will offset losses from the drop in IGM Biosciences' long position.Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
IGM Biosciences vs. Avidity Biosciences | IGM Biosciences vs. Cullinan Oncology LLC | IGM Biosciences vs. Mineralys Therapeutics, Common | IGM Biosciences vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Directory Find actively traded commodities issued by global exchanges |